US Silent Heart Attack Market to Reach $3.7 Billion by 2035

US silent attack market was valued at $1.8 billion in 2025 and is projected to reach $3.7 billion by 2035, growing at a CAGR of 7.2% from 2026 to 2035. Growth is primarily driven by the increasing prevalence of cardiovascular diseases and the growing demand for early detection technologies. According to the World Health Organization (WHO), cardiovascular diseases account for nearly 19.8 million casualties globally each year, representing about 32% of total mortality. This alarming statistic underscores the need for advanced diagnostic solutions such as ECG systems, cardiac biomarker testing, and imaging technologies, which are critical for identifying silent myocardial infarctions in the U.S. healthcare system.

Browse the full report description of “US Silent Heart Attack Market Size, Share & Trends Analysis Report by Diagnostic (ECG, Cardiac Biomarkers Testing, Cardiac Imaging, Wearable & Remote Monitoring Devices), by Treatment Type (Pharmacological Treatment, Interventional Procedures, Lifestyle & Preventive Management), by End-User (Hospitals, Cardiology Clinics, Diagnostic Centers, Homecare Settings), and Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/us-silent-heart-attack-market

Competitive Landscape of the US Silent Heart Attack Market

The key players in the U.S. silent heart attack market include top companies such as Abbott Laboratories, Medtronic, Siemens Healthineers, Danaher, and Philips Healthcare, among others. The market is experiencing steady expansion due to increased adoption of advanced diagnostic tools such as high-sensitivity troponin testing, cardiac imaging systems, and wearable monitoring devices. Hospitals and cardiology clinics are enhancing diagnostic capabilities to detect asymptomatic cardiac events, improving patient outcomes, and reducing long-term complications.

• In March 2026, Medtronic announced results from its ALERT trial demonstrating that AI-enabled clinician alerts significantly improved the evaluation and treatment of patients with heart valve disease. The study showed a 40% increase in valve interventions and improved timely clinical decision-making through automated electronic health record notifications.

• In January 2026, Boston Scientific announced the presentation of multiple clinical studies at the NANS 2026 meeting, highlighting long-term outcomes of spinal cord stimulation therapies for chronic pain management. The studies demonstrated sustained efficacy and advancements in neuromodulation technologies, reinforcing innovation in minimally invasive medical devices.

• In August 2025, Abbott announced that its Navitor transcatheter aortic valve implantation (TAVI) system received CE Mark approval for an expanded indication to treat patients with severe aortic stenosis at low and intermediate surgical risk. The minimally invasive device is now available for patients across all surgical risk categories, significantly expanding the eligible treatment population.

Market Coverage

• The market number available for – 2025–2035
• Base year- 2025
• Forecast period- 2026–2035
• Segment Covered-
• By Diagnostic
• By Treatment Type
• By End User
• Competitive Landscape: Abbott Laboratories, Medtronic, Siemens Healthineers, Danaher, and Philips Healthcare, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

US Silent Heart Attack Market Report Segment

By Diagnostic

• Electrocardiogram (ECG)
• Cardiac Biomarkers Testing (Troponin, CK-MB)
• Cardiac Imaging
• Wearable & Remote Monitoring Devices

By Treatment Type

• Pharmacological Treatment
• Interventional Procedures
• Lifestyle & Preventive Management

By End User

• Hospitals
• Cardiology Clinics
• Diagnostic Centers
• Homecare Settings

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-silent-heart-attack-market